相关实验视频

Updated: Jun 4, 2025

Murine Full-thickness Skin Transplantation

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

移植不耐症综合征使再移植复杂化

Manuel Parra Collado¹, Paula Gandía Ureña¹, Eva Gavela Martínez¹

¹Doctor Peset University Hospital, Valencia, Spain.

Transplantation proceedings

|January 4, 2025

概括

移植不耐症综合征 (GIS) 在早期移植失败中很常见,导致贫血和疼痛. 它增加了HLA敏感度,降低了再移植的可能性,通常需要移植栓塞.

科学领域:

腎臟病學 (nephrology) 是一種醫學.
移植免疫学移植免疫学

背景情况:

非功能性移植影响~4%的发生性透析患者.
完全的免疫抑制退出风险会导致HLA敏感化和移植不耐症综合征 (GIS).

研究的目的:

调查移植不耐症综合征 (GIS) 的患病率,临床表现和结果.
为了确定患有移植衰竭的患者GIS发展的预测因素.

主要方法:

对63名患有移植衰竭的患者进行了回顾性观察性研究 (2012-2022年).
排除由于血栓形成或技术问题导致的直接移植损失.
对人口统计学,临床特征,GIS演变以及与非GIS患者进行比较的分析.

主要成果:

36.5%的患者患有GIS,主要表现为贫血和移植疼痛.
GIS与增加的HLA敏感性和较低的再移植率 (比25%低4.3%) 有关.
移植后2年内移植失败是GIS的重要预测因素 (HR=2.740).

结论:

在早期的移植失败 (2年内) 中,GIS更为普遍.
尽管加强了免疫抑制,但许多GIS患者需要移植栓塞.
GIS对HLA敏感性和再移植潜力产生负面影响.

更多相关视频

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

相关概念视频

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Cell-mediated Immune Responses

Cell-mediated Immune Responses